PT92780A - Processo para a preparacao de granulos de aspirina de libertacao controlada - Google Patents

Processo para a preparacao de granulos de aspirina de libertacao controlada

Info

Publication number
PT92780A
PT92780A PT92780A PT9278090A PT92780A PT 92780 A PT92780 A PT 92780A PT 92780 A PT92780 A PT 92780A PT 9278090 A PT9278090 A PT 9278090A PT 92780 A PT92780 A PT 92780A
Authority
PT
Portugal
Prior art keywords
preparation
aspirin granules
controlled liberation
liberation
controlled
Prior art date
Application number
PT92780A
Other languages
English (en)
Other versions
PT92780B (pt
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,832 external-priority patent/US4970081A/en
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PT92780A publication Critical patent/PT92780A/pt
Publication of PT92780B publication Critical patent/PT92780B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT92780A 1989-01-03 1990-01-03 Processo para a preparacao de granulos de aspirina de libertacao controlada PT92780B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/293,832 US4970081A (en) 1989-01-03 1989-01-03 Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US42662089A 1989-10-24 1989-10-24

Publications (2)

Publication Number Publication Date
PT92780A true PT92780A (pt) 1990-07-31
PT92780B PT92780B (pt) 1997-12-31

Family

ID=26968181

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92780A PT92780B (pt) 1989-01-03 1990-01-03 Processo para a preparacao de granulos de aspirina de libertacao controlada

Country Status (20)

Country Link
EP (1) EP0377439B1 (pt)
JP (1) JP2966871B2 (pt)
KR (1) KR0151590B1 (pt)
AR (1) AR244548A1 (pt)
AT (1) ATE127690T1 (pt)
AU (1) AU622254B2 (pt)
CA (1) CA2006975C (pt)
DE (1) DE69022251T2 (pt)
DK (1) DK0377439T3 (pt)
ES (1) ES2076975T3 (pt)
FI (1) FI95776C (pt)
GR (1) GR3017576T3 (pt)
HK (1) HK35396A (pt)
IE (1) IE69270B1 (pt)
IL (1) IL92854A (pt)
MX (1) MX174376B (pt)
MY (1) MY104871A (pt)
NO (1) NO177127C (pt)
NZ (1) NZ231954A (pt)
PT (1) PT92780B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
TR200000111T2 (tr) * 1997-06-11 2000-05-22 The Procter & Gamble Company Gelişmiş üst gastrointestinal traktus güvenliği için film kaplı tablet.
CA2593593A1 (en) * 2005-01-06 2006-07-13 Cv Therapeutics, Inc. Sustained release pharmaceutical formulations comprising ranolazine
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
KR101109633B1 (ko) * 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
ES2954452T3 (es) * 2015-10-09 2023-11-22 Bayer Healthcare Llc Formulación de liberación modificada de naproxeno sódico
TWI800597B (zh) * 2018-01-30 2023-05-01 日商日東電工股份有限公司 經皮吸收型製劑

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
AU618589B2 (en) * 1988-04-05 1992-01-02 Kyowa Hakko Kogyo Co. Ltd. Oral compositions for ruminants
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
DE69022251T2 (de) 1996-05-02
IE69270B1 (en) 1996-08-21
KR0151590B1 (ko) 1998-10-15
KR900011453A (ko) 1990-08-01
FI95776C (fi) 1996-03-25
MX18883A (es) 1993-09-01
JPH02262520A (ja) 1990-10-25
JP2966871B2 (ja) 1999-10-25
DE69022251D1 (de) 1995-10-19
ES2076975T3 (es) 1995-11-16
EP0377439B1 (en) 1995-09-13
CA2006975C (en) 2000-04-04
IL92854A0 (en) 1990-09-17
DK0377439T3 (da) 1995-10-30
ATE127690T1 (de) 1995-09-15
CA2006975A1 (en) 1990-07-03
GR3017576T3 (en) 1995-12-31
EP0377439A2 (en) 1990-07-11
AU622254B2 (en) 1992-04-02
NZ231954A (en) 1991-12-23
NO177127B (no) 1995-04-18
FI95776B (fi) 1995-12-15
EP0377439A3 (en) 1991-02-06
AR244548A1 (es) 1993-11-30
PT92780B (pt) 1997-12-31
HK35396A (en) 1996-03-08
MY104871A (en) 1994-06-30
IE894120L (en) 1990-07-03
MX174376B (es) 1994-05-11
NO900009L (no) 1990-07-04
FI900017A0 (fi) 1990-01-03
NO900009D0 (no) 1990-01-02
AU4719489A (en) 1990-07-12
NO177127C (no) 1995-07-26
FI900017L (fi) 1990-07-04
IL92854A (en) 1994-11-28

Similar Documents

Publication Publication Date Title
BR8904890A (pt) Processo para a preparacao de um produto
PT97433A (pt) Processo para a preparacao de sacarose-6-ester
PT92534A (pt) Processo para a preparacao de compostos azabiciclicos
PT90293A (pt) Processo para a preparacao de macrolidos
PT91068A (pt) Processo para a preparacao de compostos biarilo
BR8901955A (pt) Processo para a preparacao de polimeros
PT91895A (pt) Processo para a preparacao de 9h-purinas substituidas
PT92786A (pt) Processo para a preparacao de compostos de tiazol
PT91872A (pt) Processo para a preparacao de compostos azabiciclicos
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT90266A (pt) Processo para a preparacao de compostos azabiciclicos
PT90854A (pt) Processo para a preparacao de 1-aril-2-naftoilaminas
PT92638A (pt) Processo para a preparacao de poliazamacrociclos mono-n-alquilados
BR9001503A (pt) Processo para a preparacao de alquil-halogenossilanos
BR8900175A (pt) Processo para a preparacao de um produto de ciclopolidiorganossiloxano
PT97828A (pt) Processo para a preparacao de fenil-triazinas
BR8901977A (pt) Processo para a preparacao de polimeros
BR8903367A (pt) Processo para a preparacao de organoclorossilanos
PT92507A (pt) Processo para a preparacao de alfa-ciano-beta-oxopropionamidas
PT90830A (pt) Processo para a preparacao de compostos macrolidos polienicos
PT92780A (pt) Processo para a preparacao de granulos de aspirina de libertacao controlada
BR8902030A (pt) Processo para a preparacao de n-fosfonometilglicina
PT94890A (pt) Processo para a preparacao de compostos azofenilicos
PT89954B (pt) Processo para a preparacao de pirroloquinolina-e pirrolofenotiazina-carboxamidas e de compostos afins
BR9002408A (pt) Processo para a producao de poliarilatos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19970917

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120917